RxDoctor Payments Data

Justin Taylor

Psychiatric/Mental Health · Hattiesburg, MSNPI 1952034456

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 221 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 20 manufacturers reported payments, led by AbbVie at 25.4% of the total.

$4,136in general payments, 2019–2025

Across 221 payments — averaging $18.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$1K
  • Vanda Pharmaceuticals Inc.$306
  • Axsome Therapeutics, Inc.$276
  • Otsuka America Pharmaceutical, Inc.$243
  • Corium, LLC$237
  • plus $991 from 14 others

What the payments were for

  • Food & beverage$4,136100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,136 in reported general payments places this provider in the 85th percentile of 486 psychiatric/mental health providers in Mississippi.

See all psychiatric/mental health providers in Mississippi

Most prescribed under Part D

DrugClaimsCost to plans & patients
VraylarCariprazine Hcl26$42,179
CaplytaLumateperone Tosylate20$32,080
Guanfacine Hcl15$483
Prazosin Hcl27$479
Quetiapine Fumarate48$430
Duloxetine Hcl20$404
Bupropion Hcl SrBupropion Hcl28$320
Olanzapine27$320
Hydroxyzine Hcl21$160
Fluoxetine Hcl22$150
Trazodone Hcl38$146
Paroxetine Hcl24$132
Sertraline Hcl24$108
Lithium Carbonate16$87
Escitalopram Oxalate11$80

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieVraylar$1,049$42,17926 claims
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta$1,033$32,08020 claims
Lilly USA, LLCOlanzapine$22$32027 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 486 psychiatric/mental health providers in Mississippi.

Other psychiatric/mental health in Hattiesburg

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →